Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum
This study has been completed.
Study NCT00448253   Information provided by Cangene Corporation
First Received: March 14, 2007   Last Updated: January 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Symptoms of Inhalational Anthrax
Additional conditions recognized in this trial
Anthrax
Pneumonia
More general conditions related to this trial
Bacillaceae Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
NP-015
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Cangene Corporation
Department of Health and Human Services


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services